News & Updates

The Washington Post: Gilead CEO insists federal government patent for HIV prevention pill Truvada is invalid

“This treatment was developed as a result of investment made by the American taxpayers,” said House Oversight Committee Chairman Elijah E. Cummings (D-Md.). “The problem is that Gilead, the company that now sells the drug, charges astronomical prices.”